Ceptur Therapeutics
Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases
All edits by Ruslan Aliyev
Edits on 10 Feb, 2022
Ruslan Aliyev
Edits made to:
Infobox (+1 properties)
Description (+128 characters)
Article (+313 characters)
Table (+2 rows) (+2 cells) (+32 characters)
Table (+1 rows) (+4 cells) (+105 characters)
Table (+1 rows) (+3 cells) (+61 characters)
Categories (+3 topics)
Ceptur Therapeutics
Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases
Article
Ceptur is developing unique and differentiated genetic medicines for patients with unaddressed diseases. The Company’s wholly owned and proprietary U1 Adaptor technology promotes non-genotoxic and long-lasting silencing of disease-causing genes in difficult to target tissues (i.e., outside of the liver and CNS).
Table
Table
Table
Infobox
Email address
contactus@cepturtx.com
Ruslan Aliyev
Edits made to:
Infobox (+2 properties)
Ceptur Therapeutics
Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases
Infobox
Is a
Website
Find more companies like Ceptur Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.